RE:RE:PromotionNEUTRAL?
More than a 90% drop since this time last year is hardly "neutral."
Oh, he must mean neutral going forward from the point that it COMPLETELY BOTTOMED OUT!
I need a 5x from here just to get back to even and others are surely worse off. This company should NEVER have been priced above 20 cents since inception in Nov. 2014. All hype, pump and fluff. A flashy website and interview after interview of how groundbreaking and game-changing this tech is. And, yes, I believe it. But the company still should never have been priced above $.20 until they make some progress.
The April 27, 2015 revelation that they were just opening an office pretty much did the SP in. It was already down 50% (mid-40s) when that NR hit. Two days later the SP lost ANOTHER 50% and closed at $.23.
I resisted buying until $.35, then thought I was getting the deal of the century what with all the big talk by Rancid Rashid and the almost 3x price drop. Then the "Office" NR and the Shhitsville spiral...
And so here we are, another 5x lower than my buy-in... and still going nowhere fast. It's already tax-loss season, so if positive clinical results do not come by year's end, this thing will go to a penny. And I will be forced to buy again as much as I loathe the idea.
--
DerekForeal wrote: the ceo said during the Oct 28 interview, that everything will be on neutral until we get the results from the 200 patients ( 1st or 2nd week of Dec). They want to make sure that the tech is solid before raising additional capital. Wait for the trial results nr in Dec and then expect promotion and price support.
The stock has a low float which causes significant price volatility and leaves a lot of room for day traders trading on fear. Anyone can trade under anonymous... don`t forget. It could be that guy who bought at 0.05 and cashing that 40% profit.
The fact that the company is not worried about the sp, desperately trying to support it with bs insider buying and nr tells you that they are confident in the long run.